Regeneron Expects to Report Biomarker Data for COVID-19 Therapy by September End Regeneron Expects to Report Biomarker Data for COVID-19 Therapy by September End

Regeneron Pharmaceuticals said on Wednesday it expects to report biomarker data for its COVID-19 antibody cocktail by the end of this month.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news